Anti-PLA2R antibodies (Ab) are a diagnostic and prognostic biomarker in primary
membranous nephropathy (PMN). We assessed the relationship between the levels of anti …

Background Membranous nephropathy (MN) is the leading cause of nephrotic syndrome in
adults. Anti-M-type phospholipase A2 receptor (anti-PLA2R) antibodies are found in most …

Background: Anti-phospholipase A2 receptor antibody (PLA2R-Ab) is useful in diagnosing
idiopathic membranous nephropathy (IMN). We investigated the clinical relevance of PLA2R …

The data were presented in abstract form at the 45th meeting of the American Society of
Nephrology, October 30-November 04 2012, San Diego, CA, USA. Circulating …

Background The diagnostic performance of PLA2R and IgG subclass staining of kidney
biopsies relative to anti-PLA2R seropositivity in the differentiation of primary and secondary …

The M-type phospholipase A2 receptor (PLA2R) is a target autoantigen in adult idiopathic
membranous nephropathy (MN), but the prevalence of autoantibodies against PLA2R is …

Introduction Primary membranous nephropathy (PMN) is associated with the anti-
phospholipase A2 receptor (anti-PLA2R) antibody in 70% of cases. Some anti-PLA2R …

Background Circulating serum autoantibodies against the M-type phospholipase A2
receptor (PLA2R-AB) are a key biomarker in the diagnosis and monitoring of primary …

Background: The diagnostic role of circulating anti-phospholipase A2 receptor antibodies
(anti-PLA2R Abs) is now well recognized in idiopathic membranous nephropathy (iMN) …

Purpose The meta-analysis aims to investigate the relationship between anti-phospholipase
A2 receptor autoantibody (anti-PLA2R) and clinical characteristics and adverse outcomes of …